What is Supernus Pharmaceuticals's net margin?

Supernus Pharmaceuticals (SUPN) reported net margin of -3.7% in Q1 2026.

How has Supernus Pharmaceuticals's net margin changed year-over-year?

Supernus Pharmaceuticals's net margin decreased by 140.3% year-over-year, from 9.3% to -3.7%.

What is the long-term trend for Supernus Pharmaceuticals's net margin?

Over 5 years (2020 to 2025), Supernus Pharmaceuticals's net margin has grown at a -26.1% compound annual growth rate (CAGR), from 24.4% to -5.4%.

What does net margin mean?

Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Supernus Pharmaceuticals SUPN Net margin

Net margin at other companies

AbbVieABBV

5.8%-1.5pp

Catalyst PharmaceuticalCPRX

37.1%+0.2pp

Axsome TherapeuticsAXSM

-26.6%-9.8pp

Neurocrine BiosciencesNBIX

21.6%+8.9pp

Jazz PharmaceuticalsJAZZ

-8.9%-20.5pp

Acadia PharmaceuticalsACAD

34.3%+11.3pp

Other financials

Income statement

See full

Revenue$207.7M+38.6%

Gross profit$184.3M+37.5%

Operating income-$8.3M+18.8%

Net income-$2.3M+80.6%

EPS (diluted)-$0.04+81.0%

Balance sheet

See full

Cash & equivalents$186.3M+60.8%

Total debt$40.9M+26.6%

Total equity$1.1B+4.5%

Total assets$1.5B+11.4%

Cash flow

See full

Operating cash flow$66.5M+117%

CapEx--100%

Free cash flow$66.5M+120%

Valuation

See full

Market cap$2.58B+62.8%

Enterprise value$2.44B+62.3%

P/S3.3×+0.9×

Profitability

See full

Gross margin89.4%+1.0pp

Operating margin-7.8%-18.9pp

FCF margin27.9%+3.4pp

Returns & leverage

See full

Return on equity-2.8%-9.1pp

Debt / equity0×0.0×

Current ratio2×-0.5×

Where this comes from

Calculated from Supernus Pharmaceuticals’s reported figures.

net income/total revenue=-3.7%

Based on trailing twelve months.

The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Supernus Pharmaceuticals's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Supernus Pharmaceuticals's net margin?: Supernus Pharmaceuticals (SUPN) reported net margin of -3.7% in Q1 2026.
How has Supernus Pharmaceuticals's net margin changed year-over-year?: Supernus Pharmaceuticals's net margin decreased by 140.3% year-over-year, from 9.3% to -3.7%.
What is the long-term trend for Supernus Pharmaceuticals's net margin?: Over 5 years (2020 to 2025), Supernus Pharmaceuticals's net margin has grown at a -26.1% compound annual growth rate (CAGR), from 24.4% to -5.4%.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.